Citi Reiterates $130 PT on Ultragenyx Pharma (RARE), Opens Catalyst Watch
Tweet Send to a Friend
Citi analyst Yigal Nochomovitz reiterated a Buy rating and $130.00 price target on Ultragenyx Pharma (NASDAQ: RARE).The analyst comments "Opening ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
